Literature DB >> 3632267

Idiopathic cardiomyopathies. A review of pathologic studies and mechanisms of pathogenesis.

M B Gravanis, A A Ansari.   

Abstract

The purpose of this article is to provide a critical review of our current knowledge of the pathogenic mechanisms of human cardiomyopathy in the context of accepted morphologic findings (gross, microscopic, ultrastructural) and the clinical presentation of this disease. It is our intent to emphasize the numerous difficulties encountered in categorizing patients with cardiomyopathy to pursue investigations in the pathogenesis and origins of this puzzling cardiac condition. It is our belief that such difficulties stem primarily from the existing classification of cardiomyopathies, which is mostly empirical and somewhat vague. This is particularly true in regard to the dilated cardiomyopathies that probably encompass multiple entities grouped under the umbrella of cardiomegaly and dilation. The article's objective is to summarize clinical symptoms and signs, modalities of diagnostic investigations, and prognosis for each category of cardiomyopathy. However, the main purpose of this article is to present recent findings on the origins, possible autoimmune basis of the disease, and results of immunologic studies in patients with cardiomyopathy.

Entities:  

Mesh:

Year:  1987        PMID: 3632267

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  3 in total

1.  Cardiomyopathy associated with high-dose interleukin-2 therapy.

Authors:  A C Beck; J H Ward; E H Hammond; R B Wray; W E Samlowski
Journal:  West J Med       Date:  1991-09

2.  Abnormal expression of histocompatibility and mitochondrial antigens by cardiac tissue from patients with myocarditis and dilated cardiomyopathy.

Authors:  A A Ansari; Y C Wang; D J Danner; M B Gravanis; A Mayne; N Neckelmann; K W Sell; A Herskowitz
Journal:  Am J Pathol       Date:  1991-08       Impact factor: 4.307

3.  Antibody-mediated enhancement of calcium permeability in cardiac myocytes.

Authors:  H P Schultheiss; U Kühl; I Janda; B Melzner; G Ulrich; M Morad
Journal:  J Exp Med       Date:  1988-12-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.